Norris Medicines submits standalone un-audited financial results

06 Feb 2020 Evaluate

Pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Norris Medicines has informed about submission of Standalone Un-audited Financial Results of the Company for the Quarter and nine month ended on 31st December, 2019; and Limited Review Report by Statutory Auditors on Standalone Un-audited Financial Results for the quarter and nine month ended on 31st December, 2019.

The above information is a part of company's filings submitted to BSE.

Norris Medicines Share Price

15.00 0.33 (2.25%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×